DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018
Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018
Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
Corkery, J. M. | Progress in brain research | 12 October 2018
Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models
Volgin, A. D., Yakovlev, O. A., Demin, K. A., Alekseeva, P. A., Kyzar, E. J., Collins, C., ... & Kalueff, A. V. | ACS chemical neuroscience | 25 September 2018
It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish
Eduardo-da-Silva, P., Lobao-Soares, B., Amarilha, H., Pinheiro-da-Silva, J., Silva, P. F., & Luchiari, A. C. | Frontiers in behavioral neuroscience | 27 August 2018
Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
Positive psychology in the investigation of psychedelics and entactogens: A critical review
Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. | Neuropharmacology | 29 June 2018
Cardiac arrest after ibogaine intoxication
Steinberg, C., & Deyell, M. W | Journal of arrhythmia | 12 June 2018
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. | Neuropharmacology | 5 June 2018
A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens
Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018
Are Ecstasy Induced Serotonergic Alterations Overestimated For The Majority Of Users?
Szigeti, B., Winstock, A. R., Erritzoe, D., & Maier, L. J. | Journal of Psychopharmacology | 7 May 2018
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018
Peyote’s Race Problem
Dawson, A. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018
The Use of Salvia divinorum from a Mazatec Perspective
Maqueda, A. E. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018
Evaluating the abuse potential of psychedelic drugs for medical use in humans
Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018
Is LSD toxic?
Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Branchi, I., & Kaelen, M. | Journal of Psychopharmacology | 1 February 2018
Key interindividual determinants in MDMA pharmacodynamics.
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 16 January 2017
A regulatory perspective on the evaluation of hallucinogen drugs for human use
Calderon, S. N., Hunt, J., & Klein, M. | Neuropharmacology | 24 November 2017
Regulation of human research with LSD in the United States (1949-1987)
Bonson, K. R. | Psychopharmacology | 17 November 2017
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of proteome research | 1 September 2017
MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users
Roberts, C. A., Quednow, B. B., Montgomery, C., & Parrott, A. C. | Neuroscience & Biobehavioral Reviews | 8 August 2017
Side-effects associated with ketamine use in depression: a systematic review
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. | The Lancet Psychiatry | 27 July 2017